Atea Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.66 | -$0.66 | -$0.66 |
| Q2 2024 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q3 2024 | 2 | -$0.31 | -$0.25 | -$0.29 |
| Q1 2025 | 2 | -$0.46 | -$0.37 | -$0.42 |
| Q2 2025 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q3 2025 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q4 2025 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q1 2026 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q2 2026 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q3 2026 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q4 2026 | 1 | -$0.36 | -$0.36 | -$0.36 |
Atea Pharmaceuticals, Inc. Earnings Date And Information
Atea Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.37 earnings per share for the quarter, topping analysts' consensus estimates of $-0.5 by $0.13. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Atea Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-1.63 diluted earnings per share) and currently has a price-to-earnings ratio of -1.61. Atea Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Atea Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.50 | -$0.37 | 0.13 | $0 | $0 |
| 08/07/2024 | Q2 2024 | -$0.77 | -$0.48 | 0.29 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.61 | -$0.75 | -0.14 | $0 | |
| 12/30/2023 | Q4 2023 | -$0.47 | $0 | |||
| 11/08/2023 | Q3 2023 | -$0.46 | -$0.40 | 0.06 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.47 | -$0.34 | 0.13 | $0 | |
| 05/08/2023 | Q1 2023 | -$0.51 | -$0.43 | 0.08 | $0 | |
| 02/28/2023 | Q4 2022 | -$0.45 | -$0.41 | 0.04 | $0 | |
| 11/07/2022 | Q3 2022 | -$0.44 | -$0.10 | 0.34 | $0 | |
| 08/08/2022 | Q2 2022 | -$0.52 | -$0.38 | 0.14 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.58 | -$0.50 | 0.08 | $0 | |
| 02/28/2022 | Q4 2021 | $0.17 | $1.41 | 1.24 | $192.18 M | |
| 11/12/2021 | Q3 2021 | -$0.34 | $53.47 M | $32.81 M | ||
| 08/12/2021 | Q2 2021 | $0.01 | $0.02 | 0.02 | $58.00 M | $60.39 M |
| 05/13/2021 | Q1 2021 | -$0.05 | $0.37 | 0.42 | $65.99 M | |
| 03/30/2021 | Q4 2020 | $0.25 | $48.63 M | |||
| 12/10/2020 | Q3 2020 | -$1.05 | -$0.22 | 0.83 | $0 | |
| 06/29/2020 | Q2 2020 | -$0.21 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.08 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.10 | $0 |
Atea Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Atea Pharmaceuticals, Inc.'s earnings date?
Atea Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did Atea Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Atea Pharmaceuticals, Inc. (:AVIR) reported $-0.37 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.5 by $0.13.
-
How can I listen to Atea Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Atea Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Atea Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Atea Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Atea Pharmaceuticals, Inc. generate each year?
Atea Pharmaceuticals, Inc. (:AVIR) has a recorded net income of $0. Atea Pharmaceuticals, Inc. has generated $-1.63 earnings per share over the last four quarters.
-
What is Atea Pharmaceuticals, Inc.'s price-to-earnings ratio?
Atea Pharmaceuticals, Inc. (:AVIR) has a price-to-earnings ratio of -1.61 and price/earnings-to-growth ratio is -1.12.
